Welcome to LookChem.com Sign In|Join Free

CAS

  • or

638-66-4

Post Buying Request

638-66-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

638-66-4 Usage

Description

Stearaldehyde, also known as octadecanal, is a long-chain aldehyde with the chemical formula C18H36O. It is a colorless to pale yellow liquid with a characteristic aldehyde odor. Stearaldehyde is derived from the oxidation of stearic acid, a saturated fatty acid commonly found in animal and plant fats. It is an important intermediate in the chemical industry and has various applications due to its unique chemical properties.

Uses

Used in Pharmaceutical Industry:
Stearaldehyde is used as a key intermediate in the synthesis of new anti-HIV Moloka'lamine derivatives. These derivatives have shown potential in the development of novel anti-HIV drugs, offering new treatment options for patients suffering from the disease.
Used in Analytical Chemistry:
Stearaldehyde is utilized in the preparation of fluorescently labeled dynamic amphiphiles. These amphiphiles are essential tools for the analysis of transmembrane ion transport, sensing, and cellular uptake. The fluorescent labeling allows for the visualization and tracking of these processes, providing valuable insights into cellular mechanisms and potential drug targets.
Used in Environmental Science:
Stearaldehyde has been identified as a possible volatile biomarker for Parkinson's disease. The detection of this compound in the breath or other biological samples could potentially aid in the early diagnosis and monitoring of the disease, leading to better patient outcomes and more effective treatment strategies.

Check Digit Verification of cas no

The CAS Registry Mumber 638-66-4 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,3 and 8 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 638-66:
(5*6)+(4*3)+(3*8)+(2*6)+(1*6)=84
84 % 10 = 4
So 638-66-4 is a valid CAS Registry Number.
InChI:InChI=1/C18H36O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h18H,2-17H2,1H3

638-66-4 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (O0368)  Octadecanal  >95.0%(GC)

  • 638-66-4

  • 1g

  • 1,840.00CNY

  • Detail

638-66-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name octadecanal

1.2 Other means of identification

Product number -
Other names stearic aldehyde

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:638-66-4 SDS

638-66-4Synthetic route

((E)-4-Octadec-1-enyl)-morpholine

((E)-4-Octadec-1-enyl)-morpholine

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With aq. acid for 1h; Ambient temperature;100%
stearic acid
57-11-4

stearic acid

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With 9-borabicyclo[3.3.1]nonane dimer; lithium dihydrido borata-bicyclo[3.3.0]nonane In tetrahydrofuran for 1h; Ambient temperature;99%
With thexylchloroborane-Me2SO4 In dichloromethane for 0.25h; Ambient temperature;98%
With thexylbromoborane dimethyl sulfide complex In carbon disulfide; dichloromethane at -20 - 20℃; for 1h;92%
sodium stearate
822-16-2

sodium stearate

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With 9-borabicyclo[3.3.1]nonane dimer In tetrahydrofuran for 1h; Ambient temperature;99%
lithium stearate
4485-12-5

lithium stearate

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With 9-borabicyclo[3.3.1]nonane dimer In tetrahydrofuran for 1h; Ambient temperature;99%
1-octadecanol
112-92-5

1-octadecanol

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With pyridinium chlorochromate In dichloromethane at 20℃; for 6h; Molecular sieve; Inert atmosphere;98%
With sodium bromite; 4-benzoxy-2,2,6,6-tetramethylpiperidine-N-oxyl; sodium hydrogencarbonate In dichloromethane; water for 6h; Ambient temperature;96%
With pyridine; oxygen; palladium diacetate In toluene at 80℃; for 2h;95%
Methyl stearate
112-61-8

Methyl stearate

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With diisobutylaluminium hydride In dichloromethane; toluene at -70℃; for 3h; Inert atmosphere;95%
With diisobutylaluminium hydride In toluene at -70℃; for 0.25h;30 % Spectr.
Stearoyl chloride
112-76-5

Stearoyl chloride

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With ammonium hydroxide; formic acid In diethyl ether; chloroform for 0.333333h; Ambient temperature;94%
With Amberlyst A-26 in the BH4(1-) form in column at 4-5 ml In hexane92.96%
With Pd-BaSO4; hydrogen
1-hexadecylcarboxylic acid
57-10-3

1-hexadecylcarboxylic acid

acrolein
107-02-8

acrolein

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With piperazine; 9-(2-chlorophenyl)acridine; tetrakis(acetonitrile)copper(I)tetrafluoroborate In dichloromethane at 25 - 27℃; for 14h; Reagent/catalyst; Solvent; Irradiation;87%
stearic acid ethyl ester
111-61-5

stearic acid ethyl ester

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With sodium tris(diethylamino)aluminum hydride In tetrahydrofuran; dodecane at 0℃; for 3h;84%
2-hexadecyloxirane
7390-81-0

2-hexadecyloxirane

lithium diethylamide
816-43-3

lithium diethylamide

A

n-Octadecanal
638-66-4

n-Octadecanal

B

1-diethylamino-octadecan-2-ol

1-diethylamino-octadecan-2-ol

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 12h; Yields of byproduct given;A n/a
B 83%
stearamide
124-26-5

stearamide

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With lithium-tris(diethylamino)hydridoaluminate In tetrahydrofuran for 12h; Ambient temperature;83%
Multi-step reaction with 2 steps
1: thionyl chloride
2: tin (II)-chloride; hydrogen chloride; diethyl ether / und beim Verseifen des Reaktionsprodukts mit warmem Wasser
View Scheme
octadecanoic acid tert-butoxy-methyl-amide
778628-28-7

octadecanoic acid tert-butoxy-methyl-amide

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With diisobutylaluminium hydride In tetrahydrofuran at -50 - -30℃; for 2h;83%
2-hexadecyloxirane
7390-81-0

2-hexadecyloxirane

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With 2,2,6,6-tetramethylpiperidinyl-lithium In tetrahydrofuran; hexane at 20℃; for 12h;80%
With lithium N-tert-butylisopropylamide In tetrahydrofuran at 20℃; for 16h;42%
N-methoxy-N-methyloctadecanoylamide
80783-97-7

N-methoxy-N-methyloctadecanoylamide

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With diisobutylaluminium hydride In tetrahydrofuran at 0℃; for 0.5h;71%
2-hexadecyloxirane
7390-81-0

2-hexadecyloxirane

lithium dicyclohexylamide
4111-55-1

lithium dicyclohexylamide

A

n-Octadecanal
638-66-4

n-Octadecanal

B

1-Dicyclohexylamino-octadecan-2-ol

1-Dicyclohexylamino-octadecan-2-ol

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 12h;A 63%
B 17%
N-methoxy-N-methyloctadecanoylamide
80783-97-7

N-methoxy-N-methyloctadecanoylamide

A

1-octadecanol
112-92-5

1-octadecanol

B

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With diisobutylaluminium hydride In tetrahydrofuran at -78℃; for 0.0833333h;A 25%
B 50%
2-hexadecyloxirane
7390-81-0

2-hexadecyloxirane

lithium diisopropyl amide
4111-54-0

lithium diisopropyl amide

A

n-Octadecanal
638-66-4

n-Octadecanal

B

1-Diisopropylamino-octadecan-2-ol

1-Diisopropylamino-octadecan-2-ol

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 12h;A 46%
B 26%
2-hexadecyloxirane
7390-81-0

2-hexadecyloxirane

lithium diisopropyl amide
4111-54-0

lithium diisopropyl amide

A

octadecan-2-one
7373-13-9

octadecan-2-one

B

trans-octadec-2-en-1-ol
2831-86-9, 22104-84-3, 41207-34-5

trans-octadec-2-en-1-ol

C

n-Octadecanal
638-66-4

n-Octadecanal

D

1-Diisopropylamino-octadecan-2-ol

1-Diisopropylamino-octadecan-2-ol

Conditions
ConditionsYield
In tetrahydrofuran at 20℃; for 12h; Product distribution; var. of lithium amide, ratio;A 4%
B 2%
C 27%
D 24%
2-hydroxy-1-nonadecanol
39516-65-9

2-hydroxy-1-nonadecanol

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With lead(IV) acetate; acetic acid; benzene at 50 - 60℃;
selenous acid dioctadecyl ester
119482-65-4

selenous acid dioctadecyl ester

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
at 177℃; under 0.1 Torr; Irradiation.mit UV-Licht;
oleoyl alcohol
143-28-2

oleoyl alcohol

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With nickel at 250℃;
N-methyl-stearanilide
5840-71-1

N-methyl-stearanilide

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With lithium aluminium tetrahydride; diethyl ether
2-heptadecyl-1,3-diphenyl-imidazolidine
103268-08-2

2-heptadecyl-1,3-diphenyl-imidazolidine

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With hydrogenchloride; diethyl ether
sodium stearate
822-16-2

sodium stearate

calcium diformate
544-17-2

calcium diformate

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With cyclohexane at 300℃;
2,4,6-trihexadecyl-[1,3,5]trioxane

2,4,6-trihexadecyl-[1,3,5]trioxane

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With zinc(II) chloride
10-stearoyl-phenothiazine
5420-41-7

10-stearoyl-phenothiazine

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With tetrahydrofuran; lithium aluminium tetrahydride; diethyl ether
stearonitrile
638-65-3

stearonitrile

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With lithium aluminium tetrahydride; diethyl ether at -60℃; und anschliessend mit wss.Ammomiumchlorid;
With hydrogenchloride; diethyl ether; tin(ll) chloride und beim Verseifen des Reaktionsprodukts mit warmem Wasser;
(Z)-9-octadecenoyl chloride
112-77-6

(Z)-9-octadecenoyl chloride

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With lutidine; hydrogen; palladium on activated charcoal
N-hydroxysuccinimide ester of stearic acid
56776-02-4

N-hydroxysuccinimide ester of stearic acid

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With hydrogen; palladium on barium sulfate under 760 Torr;
N,N-dimethyloctadecanamide
3886-90-6

N,N-dimethyloctadecanamide

n-Octadecanal
638-66-4

n-Octadecanal

Conditions
ConditionsYield
With lithium diethoxyaluminum hydride In diethyl ether
n-Octadecanal
638-66-4

n-Octadecanal

octadecanal oxime
94377-17-0

octadecanal oxime

Conditions
ConditionsYield
With hydroxylamine hydrochloride; sodium hydroxide In ethanol; water at 70℃; for 2h;100%
n-Octadecanal
638-66-4

n-Octadecanal

A

hepatdecane
629-78-7

hepatdecane

B

carbon monoxide
201230-82-2

carbon monoxide

Conditions
ConditionsYield
With silicon nanowire array-supported rhodium nanoparticle catalyst at 150℃; under 750.075 Torr; for 24h; Inert atmosphere;A 99%
B n/a
malonic acid
141-82-2

malonic acid

n-Octadecanal
638-66-4

n-Octadecanal

(E)-3-eicosenoic acid
90492-20-9

(E)-3-eicosenoic acid

Conditions
ConditionsYield
Stage #1: malonic acid; n-Octadecanal With 4-methyl-morpholine at 80℃; for 8h; Knoevenagel condensation;
Stage #2: With sulfuric acid In water at 20℃; for 0.5h; Knoevenagel condensation; regioselective reaction;
96.1%
n-Octadecanal
638-66-4

n-Octadecanal

1-octadecanol
112-92-5

1-octadecanol

Conditions
ConditionsYield
With water; magnesium; cadmium(II) chloride In tetrahydrofuran for 0.25h;95%
With tri-n-butyl-tin hydride; silica gel In dichloromethane for 24h; Ambient temperature;82%
With acetic acid; zinc und nachfolgende Verseifung des erhaltenen Octadecylacetats mittels alkoholischer Kalilauge;
diethoxyphosphoryl-acetic acid ethyl ester
867-13-0

diethoxyphosphoryl-acetic acid ethyl ester

n-Octadecanal
638-66-4

n-Octadecanal

C22H42O2

C22H42O2

Conditions
ConditionsYield
Stage #1: diethoxyphosphoryl-acetic acid ethyl ester With sodium hydride In tetrahydrofuran at 0℃; for 0.333333h; Inert atmosphere;
Stage #2: n-Octadecanal In tetrahydrofuran at 0℃; for 0.333333h; Inert atmosphere;
95%
n-Octadecanal
638-66-4

n-Octadecanal

methyl 2-cyanoacetate
105-34-0

methyl 2-cyanoacetate

methyl 2-amino-5-hexadecyl-thiophene-3-carboxylate

methyl 2-amino-5-hexadecyl-thiophene-3-carboxylate

Conditions
ConditionsYield
With sulfur; triethylamine for 12h; Gewald Aminoheterocycles Synthesis; Reflux; Inert atmosphere;94%
n-Octadecanal
638-66-4

n-Octadecanal

p-aminoethylbenzoate
94-09-7

p-aminoethylbenzoate

ethyl 4-(octadecylamino)benzoate
55791-66-7

ethyl 4-(octadecylamino)benzoate

Conditions
ConditionsYield
Stage #1: n-Octadecanal; p-aminoethylbenzoate With acetic acid In tetrahydrofuran at 20℃; for 0.166667h;
Stage #2: With sodium tris(acetoxy)borohydride In tetrahydrofuran at 20℃;
93%
Stage #1: n-Octadecanal; p-aminoethylbenzoate With acetic acid In tetrahydrofuran at 20℃; for 0.166667h; Inert atmosphere;
Stage #2: With sodium tris(acetoxy)borohydride In tetrahydrofuran at 20℃; Inert atmosphere;
93%
n-Octadecanal
638-66-4

n-Octadecanal

acid ethyl ester of p-fluorophenylphosphinic acid

acid ethyl ester of p-fluorophenylphosphinic acid

(4-Fluoro-phenyl)-(1-hydroxy-octadecyl)-phosphinic acid ethyl ester

(4-Fluoro-phenyl)-(1-hydroxy-octadecyl)-phosphinic acid ethyl ester

Conditions
ConditionsYield
Ambient temperature;91%
nitromethane
75-52-5

nitromethane

n-Octadecanal
638-66-4

n-Octadecanal

1-Nitrononadecan-2-ol

1-Nitrononadecan-2-ol

Conditions
ConditionsYield
With Amberlyst A-21 In diethyl ether for 48h; Henry condensation; Heating;89%
n-Octadecanal
638-66-4

n-Octadecanal

stearic acid
57-11-4

stearic acid

Conditions
ConditionsYield
With dihydrogen peroxide In water at 100℃; for 6h; Catalytic behavior; Green chemistry;87%
n-Octadecanal
638-66-4

n-Octadecanal

(carbethoxyethylidene)triphenylphosphorane
21382-82-1

(carbethoxyethylidene)triphenylphosphorane

ethyl (E)-2-methyleicos-2-enoate
153338-09-1

ethyl (E)-2-methyleicos-2-enoate

Conditions
ConditionsYield
In dichloromethane for 1h; Ambient temperature;84%
In dichloromethane at 20℃;
n-Octadecanal
638-66-4

n-Octadecanal

O-tert-butyl-L-serine methyl ester hydrochloride
17114-97-5

O-tert-butyl-L-serine methyl ester hydrochloride

N-octadecyl-O-tert-butylserine methyl ester
1162684-90-3

N-octadecyl-O-tert-butylserine methyl ester

Conditions
ConditionsYield
Stage #1: O-tert-butyl-L-serine methyl ester hydrochloride With triethylamine In 1,2-dichloro-ethane for 0.25h;
Stage #2: n-Octadecanal With sodium tris(acetoxy)borohydride In 1,2-dichloro-ethane at 20℃; Inert atmosphere;
84%
With sodium tris(acetoxy)borohydride
n-Octadecanal
638-66-4

n-Octadecanal

ethyl 2-((1R,2R,5R)-2-hydroxypinan-3-imino)glycinate
127593-79-7

ethyl 2-((1R,2R,5R)-2-hydroxypinan-3-imino)glycinate

ethyl {1R-[1α,2β,3(2R,3R),5α]}-3-hydroxy-2-{(2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]hept-3-ylidene)amino}icosanoate

ethyl {1R-[1α,2β,3(2R,3R),5α]}-3-hydroxy-2-{(2-hydroxy-2,6,6-trimethylbicyclo[3.1.1]hept-3-ylidene)amino}icosanoate

Conditions
ConditionsYield
With tris(ethoxy)monochloro titanium; triethylamine In dichloromethane at 0℃;83%
cycl-isopropylidene malonate
2033-24-1

cycl-isopropylidene malonate

n-Octadecanal
638-66-4

n-Octadecanal

2,2-dimethyl-5-(octadecylidene)-1,3-dioxane-4,6-dione

2,2-dimethyl-5-(octadecylidene)-1,3-dioxane-4,6-dione

Conditions
ConditionsYield
With pyrrolidine acetic acid In neat (no solvent) at 0℃; for 1.5h; Knoevenagel Condensation; Green chemistry;83%
Stage #1: cycl-isopropylidene malonate; n-Octadecanal With piperdinium acetate In dichloromethane at 0℃; for 0.75h; Knoevenagel Condensation;
Stage #2: In dichloromethane at 20℃; for 0.25h; Knoevenagel Condensation; Molecular sieve;
83%
n-Octadecanal
638-66-4

n-Octadecanal

eschenmoser's salt
33797-51-2

eschenmoser's salt

2-Methylene-octadecanal
852525-43-0

2-Methylene-octadecanal

Conditions
ConditionsYield
In dichloromethane at 20℃;82%
n-Octadecanal
638-66-4

n-Octadecanal

(tert-Butoxycarbonylmethylene)triphenylphosphorane
86302-43-4

(tert-Butoxycarbonylmethylene)triphenylphosphorane

tert-butyl (2E)-2-octadecenoate

tert-butyl (2E)-2-octadecenoate

Conditions
ConditionsYield
In dichloromethane at 25℃; for 12h; Wittig Rearrangement;82%
In dichloromethane at 20℃; for 12h; Wittig Olefination;81.7%
n-Octadecanal
638-66-4

n-Octadecanal

methyl beta-D-glucopyranoside
709-50-2

methyl beta-D-glucopyranoside

C25H48O6

C25H48O6

Conditions
ConditionsYield
With toluene-4-sulfonic acid; orthoformic acid triethyl ester In N,N-dimethyl-formamide at 70℃; under 165.017 Torr; for 5h;81%
n-Octadecanal
638-66-4

n-Octadecanal

{[(difluoromethyl)selanyl]methyl}benzene

{[(difluoromethyl)selanyl]methyl}benzene

Se-(difluoromethyl) octadecaneselenoate

Se-(difluoromethyl) octadecaneselenoate

Conditions
ConditionsYield
With 2,2'-azobis(isobutyronitrile) In 1,2-dichloro-ethane at 50℃; for 24h; Inert atmosphere;81%

638-66-4Relevant articles and documents

Jietacins, azoxy antibiotics with potent nematocidal activity: Design, synthesis, and biological evaluation against parasitic nematodes

Sugawara, Akihiro,Kubo, Masahiko,Hirose, Tomoyasu,Yahagi, Kyoichi,Tsunoda, Noriaki,Noguchi, Yoshihiko,Nakashima, Takuji,Takahashi, Yoko,Welz, Claudia,Mueller, Dennis,Mertens, Christina,Koebberling, Johannes,ōmura, Satoshi,Sunazuka, Toshiaki

, p. 524 - 538 (2018)

Jietacins, an azoxy antibiotic class of chemicals, were isolated from the culture broth of Streptomyces sp. KP-197. They have a unique structural motif, including a vinyl azoxy group and a long acyclic aliphatic chain, which is usually branched but non-branched in the case of jietacin C. During a drug discovery program, we found that jietacins display potent anthelmintic activity against parasitic nematodes and that jietacin A has a moderate or low acute toxicity (LD50 > 300 mg/kg) and no mutagenic potential in a mini Ames screen. This suggests that jietacins have potential for drug discovery research. In order to create a novel anthelmintic agent, we performed design, synthesis, and biological evaluation of jietacin derivatives against parasitic nematodes. Of these derivatives, we found that a fully synthesized simplified derivative exhibited better anthelmintic activity against three parasitic nematodes than natural jietacins. In addition, it had a better efficacy in vivo through oral administration against a mouse nematode. This indicated that the azoxy motif could prove useful as a template for anthelmintic discovery, possibly creating a class of anthelmintic with novel skeletons, a potential new mode of action, and providing further insight for rational drug design.

Hanishenols A-B, novel linear or methyl-branched glycerol enol ethers of the axinellid sponge Acanthella carteri (= Acanthella aurantiaca) from the Hanish Islands, Southern Red Sea

Mancini, Ines,Guella, Graziano,Pietra, Francesco,Amade, Philippe

, p. 2625 - 2628 (1997)

The axinellid sponge Acanthella carteri Dendy, 1889 (= Acanthella aurantiaca Keller, 1889) from the Hanish Islands, Yemen, on EtOH extraction followed by FC and HPLC purification gave the first example of branched glycerol enol ether, hanishenol B (3) alongside a major unbranched analogue, hanishenol A (1). Their structures were elucidated from NMR and MS spectra and through the ozonolysis product of 1, while the absolute configuration was assigned from exciton coupling with the dibenzoate derivative 2.

Balancing the efficacy vs. the toxicity of promiscuous natural products: Paclitaxel-based acid-labile lipophilic prodrugs as promising chemotherapeutics

Chittiboyina, Amar G.,Claudio, Pier Paolo,Haider, Saqlain,McChesney, James D.,Penfornis, Patrice

, (2021/10/19)

TumorSelect is an anticancer technology that combines cytotoxics, nanotechnology, and knowledge of human physiology to develop innovative therapeutic interventions with minimal undesirable side effects commonly observed in conventional chemotherapy. Tumors have a voracious appetite for cholesterol which facilitates tumor growth and fuels their proliferation. We have transformed this need into a stealth delivery system to disguise and deliver anticancer drugs with the assistance of both the human body and the tumor cell. Several designer prodrugs are incorporated within pseudo-LDL nanoparticles, which carry them to tumor tissues, are taken up, internalized, transformed into active drugs, and inhibit cancer cell proliferation. Highly lipophilic prodrug conjugates of paclitaxel suitable for incorporation into the pseudo-LDL nanoparticles of the TumorSelect delivery vehicle formulation were designed, synthesized, and evaluated in the panel of 24-h NCI-60 human tumor cell line screening to demonstrate the power of such an innovative approach. Taxane prodrugs, viz., ART-207 was synthesized by tethering paclitaxel to lipid moiety with the aid of a racemic solketal as a linker in cost-effective, simple, and straightforward synthetic transformations. In addition to the typical 24-h NCI screening protocol, these compounds were assessed for growth inhibition or killing of ovarian cell lines for 48 and 72h-time intervals and identified the long-lasting effectiveness of these lipophilic prodrugs. All possible, enantiomerically pure isomers of ART-207 were also synthesized, and cytotoxicities were biosimilar to racemic ART-207, suggesting that enantiopurity of linker has a negligible effect on cell proliferation. To substantiate further, ART-207 was evaluated for its in vivo tumor reduction efficacy by studying the xenograft model of ovarian cancer grown in SCID mice. Reduced weight loss (a measure of toxicity) in the ART-207 group was observed, even though it was dosed at 2.5x the paclitaxel equivalent of Abraxane. As a result, our delineated approach is anticipated to improve patient quality of life, patient retention in treatment regimes, post-treatment rapid recovery, and overall patient compliance without compromising the efficacy of the cytotoxic promiscuous natural products.

Ortho -Substituted lipidated Brartemicin derivative shows promising Mincle-mediated adjuvant activity

Foster, Amy J.,Kodar, Kristel,Stocker, Bridget L.,Timmer, Mattie S. M.

supporting information, p. 1095 - 1103 (2020/02/22)

The macrophage inducible C-type lectin (Mincle) is a pathogen recognition receptor (PRR) that is a promising target for the development of Th1-polarising vaccine adjuvants. We recently reported on the synthesis and evaluation of lipidated Brartemicin analogues that showed Mincle agonist activity, with our lead agonist exhibiting potent Th1 adjuvant activity that was greater than that of trehalose dibehenate (TDB). Herein, we report on the efficient synthesis and subsequent biological evaluation of additional lipidated Brartemicin analogues that were designed to determine the structural requirements for optimal Mincle signalling. While all the Brartemicin analogues retained their ability to signal through Mincle and induce a functional response, the o-substituted and m,m-disubstituted derivatives (5a and 5d, respectively) induced a potent inflammatory response when using cells of both murine and human origin, with this response being the greatest observed thus far. As the inflammatory response elicited by 5a was slightly better than that induced by 5d, our findings point to o-substituted Brartemicin analogues as the preferred scaffold for further adjuvant development.

Acridine Photocatalysis: Insights into the Mechanism and Development of a Dual-Catalytic Direct Decarboxylative Conjugate Addition

Arman, Hadi D.,Dang, Hang T.,Haug, Graham C.,Larionov, Oleg V.,Nguyen, Viet D.,Nguyen, Vu T.,Vuong, Ngan T. H.

, p. 11448 - 11457 (2020/11/17)

Conjugate addition is one of the most synthetically useful carbon-carbon bond-forming reactions; however, reactive carbon nucleophiles are typically required to effect the addition. Radical conjugate addition provides an avenue for replacing reactive nucleophiles with convenient radical precursors. Carboxylic acids can serve as simple and stable radical precursors by way of decarboxylation, but activation to reactive esters is typically necessary to facilitate the challenging decarboxylation. Here, we report a direct, dual-catalytic decarboxylative radical conjugate addition of a wide range of carboxylic acids that does not require acid preactivation and is enabled by the visible light-driven acridine photocatalysis interfaced with an efficient copper catalytic cycle. Mechanistic and computational studies provide insights into the roles of the ligands and metal species in the dual-catalytic process and the photocatalytic activity of substituted acridines.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 638-66-4